Subbu Nambi
Stock Analyst at Guggenheim
(3.08)
# 1,159
Out of 5,180 analysts
75
Total ratings
34.92%
Success rate
4.87%
Average return
Main Sectors:
Stocks Rated by Subbu Nambi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLLN BillionToOne | Maintains: Buy | $120 → $100 | $69.54 | +43.80% | 2 | Mar 30, 2026 | |
| GRAL GRAIL | Maintains: Buy | $130 → $75 | $47.87 | +56.67% | 4 | Mar 30, 2026 | |
| TEM Tempus AI | Maintains: Buy | $95 → $60 | $42.90 | +39.86% | 5 | Mar 30, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $50 → $55 | $44.12 | +24.66% | 4 | Mar 30, 2026 | |
| VCYT Veracyte | Maintains: Buy | $50 → $45 | $30.50 | +47.54% | 6 | Mar 30, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $170 → $100 | $60.18 | +66.17% | 3 | Mar 30, 2026 | |
| NAUT Nautilus Biotechnology | Maintains: Buy | $2.5 → $4 | $3.38 | +18.34% | 2 | Feb 27, 2026 | |
| WAT Waters | Reiterates: Buy | $440 | $294.55 | +49.38% | 1 | Feb 10, 2026 | |
| SOPH SOPHiA GENETICS | Maintains: Buy | $6 → $7 | $4.69 | +49.25% | 2 | Jan 26, 2026 | |
| PSNL Personalis | Maintains: Buy | $12 → $13 | $6.25 | +108.00% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $144 → $170 | $122.32 | +38.98% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $135 | $85.91 | +57.14% | 8 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $47 | $23.81 | +97.40% | 3 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $58 | $34.71 | +67.10% | 5 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $21 | $12.84 | +63.55% | 2 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $12 | $8.91 | +34.68% | 4 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $230 → $270 | $185.16 | +45.82% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $275 | $185.46 | +48.28% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $84.97 | - | 1 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $16.89 | +113.14% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $7.99 | +25.16% | 1 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.36 | - | 2 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.65 | - | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $112.57 | - | 1 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.26 | - | 1 | Dec 14, 2023 |
BillionToOne
Mar 30, 2026
Maintains: Buy
Price Target: $120 → $100
Current: $69.54
Upside: +43.80%
GRAIL
Mar 30, 2026
Maintains: Buy
Price Target: $130 → $75
Current: $47.87
Upside: +56.67%
Tempus AI
Mar 30, 2026
Maintains: Buy
Price Target: $95 → $60
Current: $42.90
Upside: +39.86%
Twist Bioscience
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $55
Current: $44.12
Upside: +24.66%
Veracyte
Mar 30, 2026
Maintains: Buy
Price Target: $50 → $45
Current: $30.50
Upside: +47.54%
GeneDx Holdings
Mar 30, 2026
Maintains: Buy
Price Target: $170 → $100
Current: $60.18
Upside: +66.17%
Nautilus Biotechnology
Feb 27, 2026
Maintains: Buy
Price Target: $2.5 → $4
Current: $3.38
Upside: +18.34%
Waters
Feb 10, 2026
Reiterates: Buy
Price Target: $440
Current: $294.55
Upside: +49.38%
SOPHiA GENETICS
Jan 26, 2026
Maintains: Buy
Price Target: $6 → $7
Current: $4.69
Upside: +49.25%
Personalis
Jan 26, 2026
Maintains: Buy
Price Target: $12 → $13
Current: $6.25
Upside: +108.00%
Jan 26, 2026
Maintains: Buy
Price Target: $144 → $170
Current: $122.32
Upside: +38.98%
Jan 26, 2026
Maintains: Buy
Price Target: $115 → $135
Current: $85.91
Upside: +57.14%
Jan 26, 2026
Maintains: Buy
Price Target: $43 → $47
Current: $23.81
Upside: +97.40%
Jan 26, 2026
Maintains: Buy
Price Target: $53 → $58
Current: $34.71
Upside: +67.10%
Jan 26, 2026
Maintains: Buy
Price Target: $20 → $21
Current: $12.84
Upside: +63.55%
Jan 9, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $8.91
Upside: +34.68%
Jan 5, 2026
Maintains: Buy
Price Target: $230 → $270
Current: $185.16
Upside: +45.82%
Jan 5, 2026
Maintains: Buy
Price Target: $250 → $275
Current: $185.46
Upside: +48.28%
Oct 16, 2025
Initiates: Neutral
Price Target: n/a
Current: $84.97
Upside: -
Aug 13, 2025
Maintains: Buy
Price Target: $32 → $36
Current: $16.89
Upside: +113.14%
Apr 16, 2025
Reiterates: Buy
Price Target: $10
Current: $7.99
Upside: +25.16%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.36
Upside: -
Jun 26, 2024
Downgrades: Neutral
Price Target: n/a
Current: $19.65
Upside: -
Jun 18, 2024
Initiates: Neutral
Price Target: n/a
Current: $112.57
Upside: -
Dec 14, 2023
Initiates: Neutral
Price Target: n/a
Current: $1.26
Upside: -